Zydus Lifesciences LimitedNSE: ZYDUSLIFE

Press Release Nov 07 2022

· Issued by Zydus Lifesciences Limited

Filed with NSE · · 2 pages · English

Summary by 6ix AI

Zydus Lifesciences Limited has issued a press release regarding the receipt of an Establishment Inspection Report from the USFDA for its Moraiya manufacturing facility. The report indicates that the facility's inspection classification is Voluntary Action Indicated, following an inspection conducted earlier in the year. The company is committed to providing quality healthcare solutions and aims to transform lives through innovative discoveries.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Release

Zydus Lifesciences Limited has informed the Exchange about press release dated 07-Nov-2022 titled Zydus receives EIR with Voluntary Action Indicated (VAI) from USFDA for its Moraiya manufacturing facility

Zydus Lifesciences Limited on 6ix

Earlier from Zydus Lifesciences

Later from Zydus Lifesciences

All Zydus Lifesciences news releases